The 2022 home page of
Lederhausen Center for Cystic Fibrosis Research
at the Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SWEDEN
The Center was started by a generous support from the Palle Lederhausen Family and related Foundations
The Center will perform internationally leading research and development of new knowledge and therapies for the treatment of the disease Cystic Fibrosis
The center shall
- Conduct basic research on Cystic Fibrosis, especially the relation between the non-functional CFTR ion channel and the for Cystic Fibrosis typical viscous mucus
- Conduct research that translates new knowledge on Cystic Fibrosis into novel treatments
- Conduct initial clinical trials on patients with Cystic Fibrosis
The Center is localized to the Institute of Biomedicine, Sahlgrenska academy, University of Gothenburg and shall be an open Center and meeting point for researchers in Cystic Fibrosis in Sweden.
JANUARY 2022
Kaftrio normaliserar F508del mutationen i CFTR så att svettest hos de med minst en sådan mutation får halter under 50 där gränsvärdet för Cystisk Fibros skall vara mer än 60. Således botas grundorsaken till CF (skadade lungor kan givetvis inte repareras).
På nedanstående länk visas en aktuell förklaring till problemen med slem vid Cystisk Fibros, presenterad av professor Gunnar C. Hansson:
https://www.youtube.com/watch?v=eXpyfWBZi6c&feature=emb_logo
|
Palle Lederhausen at the inauguration of the
Lederhausen's Center for Cystic Fibrosis research
Göteborg, May 2012
Prof. Paul Quinton at the inauguration of the
Lederhausen's Center for Cystic Fibrosis research
Göteborg, May 2012
|
